FDA Warns Duodenoscope Makers Over Failure to Do Postmarket Studies

Share this post

The FDA expects Olympus, Fujifilm, and Pentax to meet their postmarketing study obligations to ensure patient safety and sets deadlines for key milestones.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply